Vistance Networks (VISN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
24 Dec, 2025Executive summary
Net sales reached $1.112 billion in Q1 2025, up 23–23.5% year-over-year, with all segments and most regions contributing to growth, driven by market recovery, CommScope NEXT initiatives, and customer inventory normalization.
Core adjusted EBITDA rose to $245 million, up 159% year-over-year, marking the fourth consecutive quarter of sequential improvement.
Adjusted EPS improved to $0.14 per share from a loss of $0.24 in Q1 2024.
Board approved a $50 million share repurchase plan, citing undervalued equity and flexibility in execution.
Completed sale of OWN and DAS businesses to Amphenol for ~$2.0 billion, with proceeds used to repay debt and improve liquidity.
Financial highlights
Gross profit increased to $468.6 million (42.1–42.2% margin), up from $295.1 million (32.8–32.9%) year-over-year.
Adjusted EBITDA from continuing operations rose to $240–$245 million (21.6–22% margin), up from $84.1 million (9.3–10.5%).
Net income attributable to common stockholders was $767.1–$784 million, including gains from discontinued operations.
Cash and cash equivalents at quarter-end were $493.3 million, with total liquidity of approximately $856 million.
Free cash flow was a use of $202–$202.4 million in Q1, reflecting operating cash outflows and capital expenditures.
Outlook and guidance
2025 core adjusted EBITDA guidance reaffirmed at $1.00–$1.05 billion.
Second half of 2025 expected to outperform the first half, with Q2 revenue and adjusted EBITDA projected to increase sequentially.
Free cash flow for 2025 expected to be break-even, with working capital and CapEx investments over $200 million.
Management expects continued growth and profitability, leveraging global manufacturing and pricing strategies to navigate tariff environments.
Transformation and restructuring costs to continue in 2025 as CommScope NEXT progresses.
Latest events from Vistance Networks
- Director elections, executive pay, auditor ratification, and incentive plan shares up for vote.VISN
Proxy filing23 Mar 2026 - Proxy outlines director elections, executive pay, auditor ratification, and major ESG progress.VISN
Proxy filing23 Mar 2026 - Core adjusted EBITDA up 176% in 2025; $10/share special distribution planned.VISN
Q4 202526 Feb 2026 - Adjusted EBITDA up nearly 20% as CCS growth offsets declines; $2.1B OWN/DAS sale to aid liquidity.VISN
Q2 20242 Feb 2026 - Core adjusted EBITDA rose 25% on strong CCS gains; OWN and DAS divestiture set for Q1 2025.VISN
Q3 202416 Jan 2026 - Q4 core sales jumped 27% and margins rose, with 2025 EBITDA guidance at $1.00–$1.05B.VISN
Q4 202421 Dec 2025 - Definitive agreement to sell CCS segment to Amphenol, pending shareholder approval and regulatory review.VISN
Proxy Filing2 Dec 2025 - CCS business sale unlocks equity, enables debt repayment, and sets up a major shareholder dividend.VISN
Proxy Filing1 Dec 2025 - $10.5B sale of CCS segment to Amphenol, pending approvals and board support.VISN
Proxy Filing1 Dec 2025